ReviewPharmaceutics2020

Nanopharmaceutics: Part I-Clinical Trials Legislation and Good Manufacturing Practices (GMP) of Nanotherapeutics in the EU.

Eliana B Souto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.